Singapore, July 31, 2008: American pharma company Abbott has previewed the ARCHITECT ci4100 Integrated System at the American Association of Clinical Chemistry (AACC) Annual Meeting. The ci4100 is an automated diagnostic analyzer that integrates immunoassay and clinical chemistry testing.

 

Expected to be available in the United States by mid-2009, subject to regulatory approvals, the ci4100 will expand Abbott's family of integrated systems, offering low-volume-testing laboratories and clinics increased productivity and performance.

 

As low-volume facilities continue to seek efficiency-enhancing solutions, the ci4100 is designed to deliver improved productivity by providing a large capacity of up to 85 onboard reagents and 180 samples that can be continuously loaded and unloaded during the testing process. The ci4100 also will effectively integrate clinical chemistry and immunoassay testing with an expansive test menu, while maintaining quick and consistent immediate turnaround times during both peak and off-peak hours. This helps low to mid-volume facilities meet the demands of increasing workloads and clinical requirements. The ci4100 can generate up to 800 clinical chemistry and 100 immunoassay tests per hour.